As of 2025-07-07, the Relative Valuation of Sinil Pharmaceutical Co Ltd (012790.KQ) is 15,241.68 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 6,700.00 KRW, the upside of Sinil Pharmaceutical Co Ltd based on Relative Valuation is 127.5%.
The range of the Relative Valuation is 12,846.57 - 18,231.24 KRW.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 16.5x | 14.6x |
| Forward P/E multiples | 12.7x - 18.1x | 15.0x |
| Fair Price | 12,846.57 - 18,231.24 | 15,241.68 |
| Upside | 91.7% - 172.1% | 127.5% |
| Date | P/E |
| 2025-07-04 | 6.35 |
| 2025-07-03 | 6.40 |
| 2025-07-02 | 6.30 |
| 2025-07-01 | 6.35 |
| 2025-06-30 | 6.24 |
| 2025-06-27 | 6.22 |
| 2025-06-26 | 6.21 |
| 2025-06-25 | 6.29 |
| 2025-06-24 | 6.29 |
| 2025-06-23 | 6.23 |
| 2025-06-20 | 6.32 |
| 2025-06-19 | 6.29 |
| 2025-06-18 | 6.31 |
| 2025-06-17 | 6.27 |
| 2025-06-16 | 6.28 |
| 2025-06-13 | 6.36 |
| 2025-06-12 | 6.42 |
| 2025-06-11 | 6.45 |
| 2025-06-10 | 6.48 |
| 2025-06-09 | 6.48 |
| 2025-06-05 | 6.44 |
| 2025-06-04 | 6.39 |
| 2025-06-02 | 6.33 |
| 2025-05-30 | 6.36 |
| 2025-05-29 | 6.30 |
| 2025-05-28 | 6.30 |
| 2025-05-27 | 6.31 |
| 2025-05-26 | 6.31 |
| 2025-05-23 | 6.32 |
| 2025-05-22 | 6.41 |
| 2025-05-21 | 6.18 |
| 2025-05-20 | 6.08 |
| 2025-05-19 | 6.05 |
| 2025-05-16 | 6.05 |
| 2025-05-15 | 6.17 |
| 2025-05-14 | 6.26 |
| 2025-05-13 | 6.21 |
| 2025-05-12 | 6.20 |
| 2025-05-09 | 6.19 |
| 2025-05-08 | 6.15 |
| 2025-05-07 | 6.14 |
| 2025-05-02 | 6.12 |
| 2025-04-30 | 6.14 |
| 2025-04-29 | 6.14 |
| 2025-04-28 | 6.13 |
| 2025-04-25 | 6.16 |
| 2025-04-24 | 6.12 |
| 2025-04-23 | 6.16 |
| 2025-04-22 | 6.16 |
| 2025-04-21 | 6.13 |